Optimal welcomes Sam Henson as Business Development Manager for the Americas Optimal welcomes Sam Henson as Business Development Manager for the Americas Sam joins the company with a strong academic and technical background, reinforcing Optimal’s commitment to advancing data-driven process control solutions worldwide Santhera announces Chief Financial Officer transition with appointment of Catherine Isted Santhera announces Chief Financial Officer transition with appointment of Catherine Isted Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, appointed as CFO effective February 24, 2025. Current CFO Andrew Smith to step down after... Glox Therapeutics appoints Dr Michael Murray as Chair and Dr Nel Moore to its SAB Glox Therapeutics appoints Dr Michael Murray as Chair and Dr Nel Moore to its SAB As Chair of the Board, Dr Michael Murray will work with the team to accelerate the company’s growth, while Dr Moore will join the scientific advisory board to support the... CTMC appoints Amy Hay as Chief Business Officer and Duane Avant as Chief Technical Officer CTMC appoints Amy Hay as Chief Business Officer and Duane Avant as Chief Technical Officer Pharma Tech Industries names Jack Milligan as VP of Business Development Pharma Tech Industries names Jack Milligan as VP of Business Development WLS promotes Michael Mora to Machine Reliability Manager WLS promotes Michael Mora to Machine Reliability Manager CARBOGEN AMCIS announces leadership transition CARBOGEN AMCIS announces leadership transition Admix Europe ApS appoints Jakob Iversholt as new Operations Manager Admix Europe ApS appoints Jakob Iversholt as new Operations Manager Touchlight appoints Will Downie as adviser to support strategic growth in synthetic DNA platforms Touchlight appoints Will Downie as adviser to support strategic growth in synthetic DNA platforms Touchlight, a pioneering leader in synthetic DNA technology, is pleased to announce the appointment of Will Downie as a key adviser to support its mission in advancing genetic... Syntegon appoints Eros Carletti as Chief Financial Officer Syntegon appoints Eros Carletti as Chief Financial Officer Replacing Dr Peter Hackel, Eros will champion the group's global growth Servier names David K. Lee Executive VP of the United States Servier names David K. Lee Executive VP of the United States As Executive Vice President, David will lead Servier's activities in the US and help to form its market strategy in this key region Admix Europe APS appoints Jonas Öberg as Managing Director for European Operation Admix Europe APS appoints Jonas Öberg as Managing Director for European Operation Öberg, from Sweden, brings extensive international industrial experience as he has held numerous leadership positions, overseen manufacturing sites and commercial operations... From RAGs to riches: AI in pharma From RAGs to riches: AI in pharma Mirit Eldor, Managing Director, Life Sciences Solutions at Elsevier, reflects on the growth and future of AI in the pharmaceutical industry Fast forward PGx research in 2025 Fast forward PGx research in 2025 Neil Ward, VP EMEA of PacBio, takes a look at the near-term future of pharmacogenes BeiGene appoints Giancarlo Benelli as Senior VP and Head of Europe BeiGene appoints Giancarlo Benelli as Senior VP and Head of Europe Giancarlo will assist the company in its efforts to bring oncology medicines to more European patients AstraZeneca appoints Iskra Reic as its International Executive Vice President AstraZeneca appoints Iskra Reic as its International Executive Vice President Iskra will be responsible for championing AstraZeneca's growth across key markets globally, as well as business strategy development